What is an Allogeneic CAR T Cell?

Short7: CRISPR-Modified CAR T-Cell Therapy for Autoimmune DiseasesПодробнее

Allogeneic CAR T Therapy for Myeloma Presentation by Swara Valsangikar at Polygence's SymposiumПодробнее

Short4: CRISPR-Modified CAR T-Cell Therapy for Autoimmune DiseasesПодробнее

Allogeneic CAR-T Immunotherapies Showing Promise for Solid Tumors with Filippo Petti CelyadПодробнее

CAR T-cell Therapy in Myeloma: What to Expect and Late EffectsПодробнее

Unleashing the Promise of T-Cell Therapy | Atara Biotherapeutics (NASDAQ: ATRA) | GCFF 2024 BioПодробнее

CAR-T Cell Therapy Manufacturing WorkflowПодробнее

BeiGene: Charting New Frontiers of Affordable Cancer Cell Therapy with iPSC Derived Allogeneic CAR TПодробнее

Short5: CRISPR-Modified CAR T-Cell Therapy for Autoimmune DiseasesПодробнее

The Allogeneic Future with Poseida's Kristin Yarema, Ph.D.Подробнее

KCAT19: an off-the-shelf cord blood-derived allogeneic CAR-T product without genome editingПодробнее

CAR-T cell therapy has worked where even an allogeneic transplant has failed: Dr Prasad NarayananПодробнее

CAR-T Cell Therapy: A New Chapter in Lupus Treatment?Подробнее

Imugene says Azer-cel could be best-in-class Allogeneic CAR TПодробнее

Azer-cel best in class Allogeneic CAR T cell therapy?Подробнее

CAR-T Versus Salvage Autologous or Allogeneic Stem Cell Transplantation for Relapsed MMПодробнее

The future of CAR-T for the treatment of lymphomaПодробнее

Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANSПодробнее

The challenges with CAR T-cell therapy for T-ALL and the progress made to overcome these challengesПодробнее